Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | RRM1 | P23921 | 1/20 | 0.35 |
| ▸ | RRM2 | P31350 | 1/20 | 0.35 |
| ▸ | RRM2B | Q7LG56 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1038171 | 0.84 | ECE1 (0.42) | CA2POLBGAAPIN1ALDH1A1 | |
| SCHEMBL9852719 | 0.84 | SMN1; SMN2 (0.53) | POLBGAAPKMSMN1; SMN2MAPT | |
| SCHEMBL2861077 | 0.81 | TGFBR1 (0.44) | MMEPOLBGAAEPHX2PKM | |
| SCHEMBL1604394 | 0.81 | FOLH1 (0.55) | GAAEPHX2 | |
| SCHEMBL7341199 | 0.77 | GAA (0.62) | POLBGAAMAPTALDH1A1 | |
| SCHEMBL3966807 | 0.77 | GAA (0.62) | POLBGAAMAPTALDH1A1 | |
| SCHEMBL7040252 | 0.77 | GAA (0.62) | POLBGAAMAPTALDH1A1 | |
| SCHEMBL6874696 | 0.75 | CPB2 (0.55) | POLB | |
| SCHEMBL7320484 | 0.74 | POLB (0.75) | MMEPOLBGAAALDH1A1HSD17B10 | |
| SCHEMBL16151790 | 0.74 | GAA (0.39) | POLBGAAPKMSMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11124693-B2 | Hydroxyalkylurethane kinetic hydrate inhibitors | INDORAMA VENTURES OXIDES LLC (US) | 2021-09-21 | — | — | US | disclosed |
| EP-3452532-B1 | SUCCINIMIDE-BASED COPOLYMERS AND USE AS HYDRATE INHIBITORS | SAUDI ARABIAN OIL CO (SA) | 2021-03-24 | — | — | EP | disclosed |
| WO-2018160306-A1 | HYDROXYALKYLURETHANE KINETIC HYDRATE INHIBITORS | HUNTSMAN PETROCHEMICAL LLC (US) | 2018-09-07 | — | — | WO | disclosed |
| CN-104039918-B | Use the method that amidine and guanidine suppression gas hydrate are formed | ECO INHIBITORS A/S (NO) | 2016-11-30 | — | — | CN | disclosed |
| US-9303201-B2 | Method of inhibiting the formation of gas hydrates using amidines and guanidines | ECO INHIBITORS AS (NO) | 2016-04-05 | — | — | US | disclosed |
| US-20140256599-A1 | METHOD OF INHIBITING THE FORMATION OF GAS HYDRATES USING AMIDINES AND GUANIDINES | ECO INHIBITORS AS (NO) | 2014-09-11 | — | — | US | disclosed |
| WO-2013053770-A1 | METHOD OF INHIBITING THE FORMATION OF GAS HYDRATES USING AMINE OXIDES | ECO INHIBITORS AS (NO) | 2013-04-18 | — | — | WO | disclosed |
| WO-2013053766-A1 | METHOD OF INHIBITING THE FORMATION OF GAS HYDRATES USING AMIDINES AND GUANIDINES | ECO INHIBITORS AS (NO) | 2013-04-18 | — | — | WO | disclosed |
| WO-2008023989-A1 | ADDITIVES FOR INHIBITING GAS HYDRATE FORMATION | UNIVERSITETET I STAVANGER (NO) | 2008-02-28 | — | — | WO | disclosed |
| EP-0828778-B1 | CLATHRATE HYDRATE INHIBITOR AND METHOD OF INHIBITING THE FORMATION OF CLATHRATE HYDRATES USING IT | NIPPON CATALYTIC CHEM IND (JP) | 2004-05-12 | — | — | EP | disclosed |
| US-6319971-B1 | CONTROLLING GAS HYDRATE FORMATION, ESPECIALLY IN PIPES AND OIL AND GAS WELLS BY USING A POLYMER MIXTURE THAT PREVENTS HYDRATE NUCLEATION; ONE POLYMER'S WEIGHT BOLTZMANN FACTOR IS HIGHER THAN THE OTHER | RF-PROCOM A/S (NO) | 2001-11-20 | — | — | US | disclosed |
| US-6232273-B1 | MACROMOLECULAR COMPOUND WITH NITROGEN-CONTAINING RING PENDANT TO THE POLYMER CHAIN, SUCH AS POLYMER OF (METH)ACRYLOYL PYRROLIDINE, PYRROLIDINOCARBONYLETHYL (METH)ACRYLATE, 2-OXO-PYRROLIDINO-ETHYL (METH)ACRYLATE, ETC. | NIPPON SHOKUBAI CO., LTD. (JP) | 2001-05-15 | — | — | US | disclosed |
| WO-1998053007-A1 | COMPOSITION FOR CONTROLLING CLATHRATE HYDRATES AND A METHOD FOR CONTROLLING CLATHRATE HYDRATE FORMATION | RF-PROCOM A/S (NO) | 1998-11-26 | — | — | WO | disclosed |
| EP-0828778-A1 | CLATHRATE HYDRATE INHIBITOR AND METHOD OF INHIBITING THE FORMATION OF CLATHRATE HYDRATES USING IT | NIPPON SHOKUBAI CO., LTD. (JP) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996038492-A1 | CLATHRATE HYDRATE INHIBITOR AND METHOD OF INHIBITING THE FORMATION OF CLATHRATE HYDRATES USING IT | NIPPON SHOKUBAI CO., LTD. (JP) | 1996-12-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256599-A1 | METHOD OF INHIBITING THE FORMATION OF GAS HYDRATES USING AMIDINES AND GUANIDINES | MAGI3, GEMIN5, GCG | MME 879/4885CA2 138/4885CA4 239/4885 |
| US-11124693-B2 | Hydroxyalkylurethane kinetic hydrate inhibitors | HDHD5, UNG, OGG1 | MME 1142/4885CA2 535/4885CA4 953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.